Search results
6 wrz 2022 · Current guidelines recommend that patients with cancer should have the priority to receive the vaccine given their immunocompromised state. The timing of administration varies depending on cancer type and treatment.
22 lut 2021 · Several medical societies and professional oncology organizations have released guidance on whether patients with cancer should receive the vaccines that protect against SARS-CoV-2,...
9 lis 2021 · Most patients with cancer develop, while receiving chemotherapy, immunotherapy, or both for a solid tumour, an adequate antibody response to vaccination with the mRNA-1273 COVID-19 vaccine. The vaccine is also safe in these patients.
In The Lancet Oncology, Leticia Monin and colleagues 4 aimed to address this issue by providing some clarity on the safety and immunogenicity of COVID-19 vaccines in patients with cancer. The authors report the first analysis of a prospective, longitudinal, observational study (SOAP-02) that enrolled patients with cancer who received the mRNA ...
16 lut 2022 · These findings support the CDC guidelines for cancer patients, which state that cancer patients receiving chemotherapy should isolate for a minimum of 20 days after their first positive PCR test . Vaccination against COVID-19 was shown to significantly reduce viral load and shedding in patients with breakthrough infections [ 56 , 57 ].
8 sie 2021 · 1. Should cancer patients or cancer survivors get COVID-19 vaccination? At this juncture, despite the lack of high-quality evidence but assuming benefits outweigh the risk, experts in various societies in unison recommend vaccination for patients with active cancer or its survivors , , , .
11 mar 2022 · In this Review, the authors provide an overview of the efficacy and immunogenicity of COVID-19 vaccines in patients with cancer, and discuss alternatives to vaccination for those who...
